This inaugural event will be attended by Richard Johnson, President and CEO of the PDA, who will discuss the PDA's organizational structure, mission, and role in guiding parenteral drug development. The event will also feature a keynote presentation by your local FDA compliance officers, Maria Kelly-Doggett and William Millar, who will be discussing lifecycle management of parenteral drugs. Officers Kelly-Doggett and Millar will also be fielding questions and providing information on local FDA resources.
There will be ample opportunities to network and connect with local experts and peers in the field. Help us celebrate the formation of our new local PDA chapter, and become a part of the rapidly growing PNW-based pharmaceutical and biopharmaceutical community to ensure our voices are heard at the national level.
Dinner and drinks will be provided. Hope to see you there!
Richard M. Johnson was named President and CEO of the Parenteral Drug Association in September 2009. In his more than 30-year career in the pharmaceutical and medical devices industry, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements, quality practices, and technical operations, especially in validation, sterilization, aseptic and sterile processing. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University.
Maria Kelly-Doggett is a Bothell, Washington-based FDA compliance officer within the Office of Regulatory Affairs, Office of Pharmaceutical Quality Operations, Division IV. She joined FDA in 2008 as an investigator and conducted domestic and foreign drug and BIMO inspections until she became a compliance officer in 2014. Prior to joining the agency, Ms. Kelly-Doggett worked for twelve years in the pharmaceutical industry. Ms. Kelly-Doggett holds a B.S. in Chemical Engineering from North Carolina State University, and a M.B.A. from Meredith College, located in Raleigh, North Carolina.
William Millar is a Portland, Oregon-based FDA compliance officer within the Office of Regulatory Affairs, Office of Pharmaceutical Quality Operations, Division IV. He joined FDA in 2008 as an investigator and conducted domestic and foreign drug inspections until he became a compliance officer in 2012. Prior to joining the agency, Mr. Millar worked in the San Francisco Bay Area pharmaceutical industry for twelve years. Mr. Millar holds a B.S. in Biochemistry from the University of Nevada-Reno, and a M.B.A. from Holy Names College, located in Oakland, California.